Three of the world’s leading vaccine manufacturers have advanced to the third phase of coronavirus vaccination testing in Nepal. The Ministry of Health and Population said that the test period has been put forward.
Nepal Health Research Council (NHRC) said that Hansi from China, Ashta Geneka from Oxford University, and Gemelia from Russia, who are in the development stage of the vaccine, are interested in testing the third phase. Council Member Secretary Dr. Pradip Gyawali, ‘Hong Si, offered to vaccinate a thousand people working for a Chinese company. The council is examining the feasibility and health protocol at its suggestion. ‘ He said.
Vaccines According to the guidelines of the World Health Organization, for the third phase of clinical trials, the vaccine manufacturer must conduct a large number of tests in different countries around the world. The Russian vaccine manufacturer also submitted a proposal to the Ministry of Health and Population. Gyawali informed.
Russian Ambassador Alexei Novikov also held first talks with the Health Ministry. Dr. Gyawali, ‘The ministry gave the responsibility for vaccination work only today. From tomorrow, the feasibility study and discussion will move forward more urgently. ‘ Council Member Secretary Dr. Gyawali said he would meet with the Russian ambassador tomorrow.
Researchers and medical teams from Nepal, in coordination with the World Health Organization (WHO) and Ashta Geneka from Oxford University in the UK, discussed vaccination tests in a webinar.
. Oxford University is committed to updating the test soon.
It is believed that Nepal can easily get vaccinated if a vaccination company conducts tests in a coordinated manner with Nepali health workers and specialists.
The council said that Ashta Zeneca from the University of Oxford in the UK and Russia were also interested in the third trial of the Kovid-19 vaccine from Genelia. The Nepal Health Research Council has been tasked with conducting research and testing activities on vaccine development in Nepal.
Sinopharm of the Wuhan Institute of Biological Products of China, Ashta Gineka from Oxford University and the Gemelia National Center for Epidemiology and Microbiology in Russia are at the forefront of vaccine development. Gamelia claimed the vaccine was effective and safe by registering in the second phase of the test.
Large-scale production of Sputnik V has already begun without testing in the third stage. The ministry said all three vaccine manufacturers from China, Britain and Russia were ready for the third phase of testing in Nepal. Council Member Secretary Dr. Pradip Gyawali said that a feasibility study had been carried out for the preparation and testing of the vaccine.
While the manufacturing company demanded success, some countries around the world even signed supply contracts with the company. Leading countries in the agreement, including Australia, Britain and Germany. Public health experts and doctors said that Nepal should also take the initiative to ensure the right to vaccination, the ministry said that all three companies have started a trial period.
However, the ministry did not provide detailed information on the procurement process. There are three different procedures to ensure the safety of the vaccine. The country wishing to receive the vaccine can enter into a direct contract with the manufacturer. Another World Health Organization buys and provides vaccines for low-income countries. Third, GABI, funded by the World Health Organization and UNICEF, manages the rights and supply of vaccinated goods in all countries, along with manufacturing companies.
GABI is expected to distribute 100 million vaccines to low- and middle-income countries by early 2021. There are 92 such middle and low income countries